Carbimazole
Carbimazole is a prodrug antithyroid agent rapidly metabolized in vivo to its active form, methimazole (MMI) . It serves as a critical research tool for investigating hyperthyroidism and Graves' disease mechanisms in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
22232-54-8
Product Name Alternative
Antithyroid agent, Athyromazole, Carbimazol, Carbimazole, methimazole, MMI, Neomercazole, inhibit, Inhibitor, Graves' disease, THR, Thyroidhormonereceptor, Thyroidhormonereceptor (THR), Thyroid hormone receptor, Thyroid hormone receptor (THR), Thyroid peroxidase
Field of Research
Metabolism Research, Pharmacology & Drug Discovery, Signal Transduction
Purity
99.22% (May vary between batches)
Solubility
Ethanol:12 mg/mL (64.44 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (10.74 mM) ; DMSO:60 mg/mL (322.18 mM)
Smiles
C (OCC) (=O) N1C (=S) N (C) C=C1
Molecular Formula
C7H10N2O2S
Molecular Weight
186.23
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
